1. SMYD3: a regulator of epigenetic and signaling pathways in cancer
   Benjamin J. Bernard et al, 2021, Clinical Epigenetics CrossRef
2. A novel small molecule ZYZ384 targeting SMYD3 for hepatocellular carcinoma via reducing H3K4 trimethylation of the Rac1 promoter
   Qian Ding et al, 2024, MedComm CrossRef
3. Cell geometry and the cytoskeleton impact the nucleo-cytoplasmic localisation of the SMYD3 methyltransferase
   David Pereira et al, 2020, Scientific Reports CrossRef
4. The function of histone methylation and acetylation regulators in GBM pathophysiology
   Colin McCornack et al, 2023, Frontiers in Oncology CrossRef
5. Therapeutical potential of deregulated lysine methyltransferase SMYD3 as a safe target for novel anticancer agents
   Gurukumari Rajajeyabalachandran et al, 2017, Expert Opinion on Therapeutic Targets CrossRef
6. The long noncoding RNA SPRIGHTLY acts as an intranuclear organizing hub for pre-mRNA molecules
   Bongyong Lee et al, 2017, Science Advances CrossRef
7. Dynamic methylation of histone H3K18 in differentiating Theileria parasites
   Kevin Cheeseman et al, 2021, Nature Communications CrossRef
8. RNaseH2A is involved in human gliomagenesis through the regulation of cell proliferation and apoptosis
   BIN DAI et al, 2016, Oncology Reports CrossRef
9. Expression pattern and prognostic significance of myosin light chain 9 (MYL9): a novel biomarker in glioblastoma
   Banavathy S Kruthika et al, 2019, Journal of Clinical Pathology CrossRef
10. S100A11 activates the pentose phosphate pathway to induce malignant biological behaviour of pancreatic ductal adenocarcinoma
    Xue Zeng et al, 2022, Cell Death & Disease CrossRef
11. Amplification of SMYD3 promotes tumorigenicity and intrahepatic metastasis of hepatocellular carcinoma via upregulation of CDK2 and MMP2
    Yu Wang et al, 2019, Oncogene CrossRef
12. Network analyses elucidate the role of SMYD3 in esophageal squamous cell carcinoma
    Xinning Liu et al, 2017, FEBS Open Bio CrossRef
13. SMYD3 promoter Hypomethylation is Associated with the Risk of Colorectal Cancer
    Bin Li et al, 2018, Future Oncology CrossRef
14. SMYD3: An Oncogenic Driver Targeting Epigenetic Regulation and Signaling Pathways
    Cinzia Bottino et al, 2020, Cancers CrossRef
15. SMYD Protein Family as Promising Biomarkers for Cancer Diagnosis and Prognosis
    Yingxue Zhang et al, 2022, Genomic and Epigenomic Biomarkers of Toxicology and Disease CrossRef
16. A Novel lncRNA IHS Promotes Tumor Proliferation and Metastasis in HCC by Regulating the ERK- and AKT/GSK-3β-Signaling Pathways
    Zheng Chen et al, 2019, Molecular Therapy - Nucleic Acids CrossRef
17. A composite network of conserved and tissue specific gene interactions reveals possible genetic interactions in glioma
    André Voigt et al, 2017, PLOS Computational Biology CrossRef
18. Analysis of SET and MYND Domain-Containing Protein 3 (SMYD3) Expression in Gallbladder Cancer: a Pilot Study
    Pushkar Chandra et al, 2021, Indian Journal of Surgical Oncology CrossRef
19. Clinical prognostic value of the SMYD2/3 as new epigenetic biomarkers in solid cancer patients: a systematic review and meta-analysis
    Mahdieh Razmi et al, 2022, Expert Review of Molecular Diagnostics CrossRef
20. Clinicopathological and Prognostic Significance of SMYD3 in Human Cancers: A Systematic Review and Meta-analysis
    Xuan Wang et al, 2022, Genetic Testing and Molecular Biomarkers CrossRef
21. Hypoxia effects on glioblastoma progression through YAP/TAZ pathway regulation
    Carolina Castillo et al, 2024, Cancer Letters CrossRef
22. Homeobox genes gain trimethylation of histone H3 lysine 4 in glioblastoma tissue
    Kun Luo et al, 2016, Bioscience Reports CrossRef